Peter S. Garcia

Chief Financial Officer, Adhera Therapeutics, Inc.

Companies

DURECT CORPBoard member Dec 14, 2021 to now¹
ALX ONCOLOGY HOLDINGS INCChief financial officer Jul 16, 2020 to Aug 16, 2024²
Lineage Cell TherapeuticsChief financial officer Oct 5, 2011 to Feb 22, 2013³
Adhera Therapeutics, Inc.Chief financial officer Jul 15, 2009 to Aug 29, 2011⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

ALX ONCOLOGY HOLDINGS INC ALXO121,516 shares⁵$115.8K at $0.95Aug 14, 2024
DURECT CORP0 shares⁶Sep 11, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

Sep 11, 2025U 12,500 shares of DURECT CORP⁶
Sep 9, 2025Exercised options 5,500 shares at $1.22 of DURECT CORP⁷
Aug 14, 2024Shares withheld for tax 761 shares at $2.58 of ALX ONCOLOGY HOLDINGS INC⁵
Jun 28, 2024Shares withheld for tax 1,789 shares at $6.03 of ALX ONCOLOGY HOLDINGS INC⁸
Jun 13, 2024Bought 12,000 shares at $8.53 of ALX ONCOLOGY HOLDINGS INC⁹
Jun 13, 2024Bought 12,000 shares at $8.53 of ALX ONCOLOGY HOLDINGS INC¹⁰
Feb 14, 2024Granted 25,000 shares of ALX ONCOLOGY HOLDINGS INC¹¹
Dec 29, 2023Sold 1,893 shares at $15.04 of ALX ONCOLOGY HOLDINGS INC¹²
Jul 25, 2023Granted 32,000 shares of ALX ONCOLOGY HOLDINGS INC¹³
Jun 30, 2023Sold 887 shares at $7.34 of ALX ONCOLOGY HOLDINGS INC¹⁴
Dec 29, 2022Sold 893 shares at $11.07 of ALX ONCOLOGY HOLDINGS INC¹⁵
Aug 5, 2022Granted 29,000 shares of ALX ONCOLOGY HOLDINGS INC¹⁶
Feb 7, 2022Exercised options 8,363 shares at $4.81 of ALX ONCOLOGY HOLDINGS INC¹⁷
Feb 7, 2022Exercised options 6,637 shares at $4.08 of ALX ONCOLOGY HOLDINGS INC¹⁷
Oct 18, 2021Sold 189 shares at $59.06 of ALX ONCOLOGY HOLDINGS INC¹⁸
Oct 18, 2021Sold 438 shares at $58.30 of ALX ONCOLOGY HOLDINGS INC¹⁸
Oct 18, 2021Sold 411 shares at $57.54 of ALX ONCOLOGY HOLDINGS INC¹⁸
Oct 18, 2021Sold 1,437 shares at $56.09 of ALX ONCOLOGY HOLDINGS INC¹⁸
Oct 18, 2021Sold 1,903 shares at $55.15 of ALX ONCOLOGY HOLDINGS INC¹⁸
Oct 18, 2021Sold 2,851 shares at $54.33 of ALX ONCOLOGY HOLDINGS INC¹⁸
Oct 18, 2021Exercised options 7,229 shares at $4.08 of ALX ONCOLOGY HOLDINGS INC¹⁸

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARDURECT CORP, Board member
2
SEC EDGARALX ONCOLOGY HOLDINGS INC, Chief financial officer
3
SEC EDGARLineage Cell Therapeutics, Chief financial officer
4
SEC EDGARAdhera Therapeutics, Inc., Chief financial officer
5
SEC EDGARALX ONCOLOGY HOLDINGS INC shares after the filing of Aug 14, 2024
6
SEC EDGARDURECT CORP shares after the filing of Sep 11, 2025
7
SEC EDGARForm 4 filed Sep 11, 2025
8
SEC EDGARForm 4 filed Jul 2, 2024
9
SEC EDGARForm 4 filed Jun 24, 2024
10
SEC EDGARForm 4 filed Jun 17, 2024
11
SEC EDGARForm 4 filed Feb 16, 2024
12
SEC EDGARForm 4 filed Jan 3, 2024
13
SEC EDGARForm 4 filed Jul 27, 2023
14
SEC EDGARForm 4 filed Jul 5, 2023
15
SEC EDGARForm 4 filed Jan 3, 2023
16
SEC EDGARForm 4 filed Aug 9, 2022
17
SEC EDGARForm 4 filed Feb 8, 2022
18
SEC EDGARForm 4 filed Oct 19, 2021